摘要
目的:观察拉米夫定联合香菇多糖用于慢性乙型肝炎的临床疗效,评价其应用价值。方法:选择68例慢性乙型肝炎患者,随机分观察组与对照组各34例,观察组采用拉米夫定联合香菇多糖进行治疗,对照组单用拉米夫定进行治疗,对两组疗效及不良反应进行比较分析,观察组间是否存在统计学差异。结果:应用拉米夫定联合香菇多糖治疗的观察组疗效明显优于对照组,病毒复制得到抑制,肝功能得以改善,组间差异具有统计学意义(P<0.05)。结论:拉米夫定联合香菇多糖用于治疗慢性乙型肝炎,具有疗效显著,安全可靠的特点。
Objective：to observe the lamivudine joint lentinan used for chronic hepatitis b clinical curative effect,and evaluate its application value.Method：choose 68 cases of chronic hepatitis b patients were randomly divided into observation of equal number with a control group,the observation group using lamivudine joint lentinan treatment,the control group with lamivudine treatment,with two groups of curative effect and adverse reaction of the comparison and analysis,observe whether there are significant differences between groups.Results：the application of lamivudine joint lentinan treatment of the observation group had better effects than control group,the virus,be suppressed,liver function is to improve,a statistically significant difference between groups（P〈0.05）.Conclusion：lamivudine joint lentinan used in the treatment of chronic hepatitis b,has the remarkable curative effect,safe and reliable,the characteristics of clinical application is worth.
